News
The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...
National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
Indian retail investors ramped up US stock purchases amid global market volatility, with a strong tilt toward semiconductors, healthcare, AI, and small-cap ETFs. There was also a shift toward ...
19h
Zacks Investment Research on MSNHims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its ...
Ives is getting in on the great ETF boom of 2025. The ETF, a basket of assets listed on an exchange just like a stock, has become a magnet for just about every existing or aspiring asset manager on ...
Executives and directors of Hims & Hers Health Inc., a leading telehealth company, are facing a shareholder derivative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results